Last edition
News about "Pharma Acquisition "
Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription
Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).
Pharma Acquisition | 20/05/2026 | By News Bureau
Octane Medical Group to Acquire Personalised Medicine Unit from Lonza
Octane Medical Group has signed an agreement to acquire the personalised medicine business of Lonza, including the Cocoon cell-therapy platform. The deal aims to expand Octane’s capabilities in advanced therapies and strengthen its presence in the rapidly growing personalised medicine sector.
Pharma Acquisition | 06/03/2026 | By News Bureau | 120
Worldwide Clinical Trials to Acquire Catalyst Clinical Research
Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a move aimed at expanding its functional service provider capabilities, strengthening its global site network, boosting oncology expertise, and accelerating technology integration to enhance efficiency and transparency for customers.
Pharma Acquisition | 21/01/2026 | By News Bureau | 279
Bayer to Enter Molecular Imaging, Acquires Pan-Amyloid Radiotracers from Attralus
By acquiring AT-01 and AT-05 from Attralus, Bayer strengthens its molecular imaging and cardiovascular precision medicine portfolio, targeting earlier and more accurate diagnosis of amyloidosis.
Pharma Acquisition | 14/01/2026 | By News Bureau | 209
Aurobindo Pharma Extends Timeline for Acquisition of Stake in Swarnaakshu Solar Power
Aurobindo Pharma has announced that the completion of its captive solar power purchase agreement and the acquisition of up to a 26 percent stake in Swarnaakshu Solar Power has been deferred to March 31, 2026, due to pending state government approvals for setting up the solar power plant.
Pharma Acquisition | 30/12/2025 | By News Bureau | 205
Exyte Completes Pharmaplan's Integration
The completed integration of Pharmaplan marks a major milestone in Exyte’s strategy to build a leading European player in life sciences engineering and strengthen collaboration with the region’s biotechnology and pharmaceutical industries.
Pharma Acquisition | 28/11/2025 | By Dineshwori | 258
PerkinElmer to acquire Nexcelom Bioscience for US$ 260 million
Nexcelom is a leading, global provider of automated cell counting instruments, image cytometry workstations, assays and a variety of cell reagents, consumables, and fit-for-purpose cell counting method selection and development instructions that follow ISO Cell Counting Standards and aid in the development of cell and gene and immuno-oncology therapies
Pharma Acquisition | 14/05/2021 | By Darshana | 285
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy